|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
145,074,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$34.98 - $34.98 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lagarde Michel |
President |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(245,939) |
0 |
|
- |
|
Wilson Dean Frederick |
Chief Accounting Officer |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(126,518) |
0 |
|
- |
|
Grant Stuart |
EVP and CFO |
|
2017-08-29 |
4 |
D |
$35.00 |
$19,831,105 |
I/I |
(566,603) |
0 |
|
- |
|
Grant Stuart |
EVP and CFO |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(196,485) |
0 |
|
- |
|
Gill Harry R Iii |
SVP, Quality/Continuous Imprvt |
|
2017-08-29 |
4 |
D |
$35.00 |
$10,678,290 |
I/I |
(305,094) |
0 |
|
- |
|
Gill Harry R Iii |
SVP, Quality/Continuous Imprvt |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(105,800) |
0 |
|
- |
|
Gill Harry R Iii |
SVP, Quality/Continuous Imprvt |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,078) |
105,800 |
|
- |
|
New Rebecca Holland |
EVP, Enterprise Operations |
|
2017-08-29 |
4 |
D |
$35.00 |
$10,030,475 |
I/I |
(286,585) |
0 |
|
- |
|
New Rebecca Holland |
EVP, Enterprise Operations |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(161,543) |
0 |
|
- |
|
New Rebecca Holland |
EVP, Enterprise Operations |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,306) |
161,543 |
|
- |
|
Schneier Craig Eric |
EVP and Chief Talent Officer |
|
2017-08-29 |
4 |
D |
$35.00 |
$1,706,425 |
D/D |
(48,755) |
0 |
|
- |
|
Lehmann Michael J. |
EVP, Global Sales and Mktng |
|
2017-08-29 |
4 |
D |
$35.00 |
$13,081,390 |
I/I |
(373,754) |
0 |
|
- |
|
Lehmann Michael J. |
EVP, Global Sales and Mktng |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(191,772) |
0 |
|
- |
|
Lehmann Michael J. |
EVP, Global Sales and Mktng |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,966) |
191,772 |
|
- |
|
Utiger Lukas |
President, Drug Substance Svcs |
|
2017-08-29 |
4 |
D |
$35.00 |
$13,081,390 |
I/I |
(373,754) |
0 |
|
- |
|
Utiger Lukas |
President, Drug Substance Svcs |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(191,772) |
0 |
|
- |
|
Utiger Lukas |
President, Drug Substance Svcs |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,420) |
191,772 |
|
- |
|
Sherbet Eric |
General Counsel and Secretary |
|
2017-08-29 |
4 |
D |
$35.00 |
$4,535,825 |
I/I |
(129,595) |
0 |
|
- |
|
Sherbet Eric |
General Counsel and Secretary |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(219,330) |
0 |
|
- |
|
Sherbet Eric |
General Counsel and Secretary |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,552) |
219,330 |
|
- |
|
Torres Raul Cardona |
SVP, Quality |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,112) |
0 |
|
- |
|
Mullen James C |
Chief Executive Officer |
|
2017-08-29 |
4 |
D |
$35.00 |
$91,528,115 |
I/I |
(2,615,089) |
0 |
|
- |
|
Mullen James C |
Chief Executive Officer |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(906,858) |
0 |
|
- |
|
Mullen James C |
Chief Executive Officer |
|
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(93,432) |
906,858 |
|
- |
|
Negron Francisco R. |
President, Drug Product Svcs |
|
2017-08-29 |
4 |
D |
$35.00 |
$11,555,915 |
I/I |
(330,169) |
0 |
|
- |
|
97 Records found
|
|
Page 1 of 4 |
|
|